The global flow cytometry market is estimated to generate revenue of USD 7 billion by 2022, registering a CAGR of 16 percent during 2015-2022. The instruments segment held a dominant share in the world flow cytometry market in 2014, and is expected to maintain its lead. Within flow cytometry instruments market, replacement components segment is projected to grow at a high CAGR of 16.3 percent during the forecast period. Reagents segment is projected to be the fastest growing segment registering a CAGR of 18.9 percent. Cell-based technology segment would continue to dominate the market. Geographically, Asia-Pacific region is projected to be the fastest growing flow cytometry market, registering a CAGR of 17.8 percent.

The market is poised to grow at a significant pace, owing to rising adoption of advanced instruments, growing popularity of flow cytometry reagents in diagnosis, recurring sales from replaceable components and consumables, and rising prevalence of diseases such as cancer and HIV.


 

randox

Digital version